Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes

NCT ID: NCT07009483

Last Updated: 2025-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-02

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In a previous part of this study, we created educational modules about the psychodermatology of inflammatory skin conditions, with a particular emphasis on atopic dermatitis, for patients. These modules will empower patients to better manage both the psychological and physical aspects of their skin conditions. As part of this project, we aim to conduct a clinical trial to determine the effectiveness of these modules on eczema severity and health-related quality of life in patients. We hope to use these findings to develop and disseminate accessible educational material on the psychological aspects of dermatologic care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis (AD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Educational Module Arm

This arm consists of participants living with atopic dermatitis that will be trialing our educational modules. In addition to receiving standard medical care, they will be asked to complete these modules throughout the duration of the study period.

Group Type EXPERIMENTAL

Patient education modules providing information on the psychological aspects of atopic dermatitis treatment and management.

Intervention Type BEHAVIORAL

Provision of online patient educational modules (in addition to patients receiving regular clinical action/ appointments at the Kaye Edmonton Clinic, the Stollery Children's Hospital, and the Rao Dermatology Clinic for Atopic Dermatitis).

Control Arm

This arm will consist of participants living with atopic dermatitis. They will receive standard medical care, but will not be given access to the educational modules until the study period has been completed.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient education modules providing information on the psychological aspects of atopic dermatitis treatment and management.

Provision of online patient educational modules (in addition to patients receiving regular clinical action/ appointments at the Kaye Edmonton Clinic, the Stollery Children's Hospital, and the Rao Dermatology Clinic for Atopic Dermatitis).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. New diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
2. Reliable internet access to be able to access the e-modules.
3. Able to speak English at a level required to understand the content of this study.
4. Child participants will be included in this study contingent on the consent of their guardian/caregiver(s).
5. Age range of eligible participants: Age 4 years and older.

Exclusion Criteria

1. Does not have a new diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
2. Unable to access and/or navigate e-modules with reasonable support/instruction.
3. Unable to speak English at a level required to understand the content of this study.
4. Unable to provide informed consent.
5. Less than 4 years of age.
Minimum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alberta

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marlene Dytoc, MD, PhD, FRCPC

Role: PRINCIPAL_INVESTIGATOR

University of Alberta

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rao Dermatology

Edmonton, Alberta, Canada

Site Status

Kaye Edmonton Clinic

Edmonton, Alberta, Canada

Site Status

Stollery Children's Hospital

Edmonton, Alberta, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Liu C, Chan M, Beard V, Mathura P, Dytoc M. Beyond Skin Deep: case-based online modules to teach multidisciplinary care in dermatology among clerkship students. BMC Med Educ. 2023 Feb 4;23(1):90. doi: 10.1186/s12909-023-04072-z.

Reference Type BACKGROUND
PMID: 36739386 (View on PubMed)

Verma L, Turk T, Dennett L, Dytoc M. Teledermatology in Atopic Dermatitis: A Systematic Review. J Cutan Med Surg. 2024 Mar-Apr;28(2):153-157. doi: 10.1177/12034754231223694. Epub 2024 Jan 11.

Reference Type BACKGROUND
PMID: 38205736 (View on PubMed)

Odeshi O, Turk T, Fiorillo L, Lowe S, Dytoc M. Teledermatology Versus In-Person Visits for the Follow-Up of Atopic Dermatitis Patients. J Cutan Med Surg. 2024 Jul-Aug;28(4):346-351. doi: 10.1177/12034754241253192. Epub 2024 May 28.

Reference Type BACKGROUND
PMID: 38807447 (View on PubMed)

Turk T, Fujiwara E, Abba-Aji A, Mathura P, Dytoc M. Psychodermatology in Canada: A National Survey Assessment of Dermatologists' Perception, Practice Patterns, and Challenges. J Cutan Med Surg. 2021 May-Jun;25(3):249-256. doi: 10.1177/1203475420977473. Epub 2020 Dec 2.

Reference Type BACKGROUND
PMID: 34039041 (View on PubMed)

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol. 2019 Sep;181(3):554-565. doi: 10.1111/bjd.17683. Epub 2019 Mar 5.

Reference Type BACKGROUND
PMID: 30838645 (View on PubMed)

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY, Chiesa Fuxench ZC. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018 Sep;121(3):340-347. doi: 10.1016/j.anai.2018.07.006. Epub 2018 Jul 16.

Reference Type BACKGROUND
PMID: 30025911 (View on PubMed)

Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, Misery L, Szabo C, Linder D, Sampogna F, Evers AWM, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015 Apr;135(4):984-991. doi: 10.1038/jid.2014.530. Epub 2014 Dec 18.

Reference Type BACKGROUND
PMID: 25521458 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00153557

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.